Application and preliminary validation of the hip inflammation MRI scoring system (HIMRISS) in spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30548414/

TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30548414/

Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis (2018)
https://pubmed.ncbi.nlm.nih.gov/30548414/

TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes (2018)
https://pubmed.ncbi.nlm.nih.gov/30548414/

Functional defects in CD4 + CD25 high FoxP3 + regulatory cells in ankylosing spondylitis (2016)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27 (2015)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy (2015)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial (2014)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Efficacy and safety of celecoxib in chinese patients with ankylosing spondylitis: a 6-week randomized, double-blinded study with 6-week open-label extension treatment (2014)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy (2013)
https://pubmed.ncbi.nlm.nih.gov/27901054/

Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies (2012)
https://pubmed.ncbi.nlm.nih.gov/27901054/